Living Diabetes is an evidence-based diabetes resource. Our editorial team curates clinical content from NICE, NHS, ADA and Diabetes UK guidelines to help readers understand and live well with diabetes.
Phase 3 retatrutide data in recent-onset type 2 diabetes showed A1C lowering and weight loss. The drug remains investigational and is not FDA-approved.
Discover delicious and filling summer salad recipes designed for diabetes management. Learn about ingredients, nutrition, and practical tips for healthy…
Discover how men with diabetes can safely and effectively incorporate strength training into their routine to improve blood sugar, build muscle, and boost…
Learn about Anti-VEGF injections for diabetes-related eye conditions, including diabetic retinopathy and macular edema, and how they can help protect your…
Navigate air travel with diabetes confidently. Learn about TSA guidelines for insulin, supplies, and devices, plus practical tips for a smooth and safe…
Learn how to exercise safely and effectively when living with diabetes complications. Get practical steps, safety tips, and guidance on when to consult…
A new FLOW analysis reports that semaglutide kidney and all-cause death benefits were consistent across cardiovascular-risk groups in adults with type 2 diabetes and chronic kidney disease.
